S A Factor. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antiparkinson Agents/administration & dosageAntiparkinson Agents/adverse effectsClinical Trials as TopicDopamine Agonists/administration & dosageDopamine Agonists/adverse effectsDrug Therapy, CombinationHumansLevodopa/administration & dosageLevodopa/adverse effectsParkinson Disease/diagnosisParkinson Disease/drug therapyTreatment Outcome
Substances： See more » Antiparkinson AgentsDopamine AgonistsLevodopa
Year: 2000 PMID： 10752599 DOI： 10.1002/1531-8257(200003)15:2<360::aid-mds1033>3.0.co;2-n
Source DB: PubMed Journal: Mov Disord ISSN： 0885-3185 Impact factor: 10.338